Projects overview

Sort by

Toggle all information

OPTOGENERAPY | Optogenetic Protein Therapy for Multiple Sclerosis

01-01-2017

-

31-01-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.3. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
H2020-EU.2.1.3.0. Cross-cutting call topics
H2020-NMBP-2016-two-stage
NMBP-09-2016 Biomaterials for diagnosis and treatment of demyelination disorders of the Central Nervous System

N2B-patch | Nose to Brain Delivery of Antibodies via the Olfactory Region for the Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device

01-01-2017

-

30-06-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.3. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
H2020-EU.2.1.3.0. Cross-cutting call topics
H2020-NMBP-2016-two-stage
NMBP-09-2016 Biomaterials for diagnosis and treatment of demyelination disorders of the Central Nervous System
Powered by Chris Decubber BV